Advertisement

Digestive Diseases and Sciences

, Volume 41, Issue 1, pp 83–87 | Cite as

Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies?

100% Positive predictive value for celiac disease in adults
  • Trausti Valdimarsson
  • Lennart Franzen
  • Ewa Grodzinsky
  • Thomas Skogh
  • Magnus Ström
Intestinal Disorders, Inflammatory Bowel Disease, Immunology, and Microbiology

Abstract

The comparative diagnostic value of IgA anti-endomysium and IgA antigliadin antibodies in adults with histologically confirmed celiac disease is reported. Sera from 144 adult patients (without concurrent dermatitis herpetiformis or IgA deficiency) who underwent small bowel biopsy were analyzed for both IgA anti-endomysium and IgA anti-gliadin antibodies. Nineteen patients (13%) had celiac disease. The presence of IgA antiendomysium antibodies had a sensitivity of 74% and a specificity of 100%. The positive and negative predictive values were 100% and 96%, respectively, and the diagnostic accuracy was 97%. In contrast, IgA anti-gliadin antibodies had positive and negative predictive values of 28% and 96%, respectively, with a diagnostic accuracy of 71%. Based on these data, we suggest that small bowel biopsy is not necessary to diagnose celiac disease in symptomatic adults with IgA antiendomysium antibodies. Due to a negative predictive value of 96%, some symptomatic adults lacking anti-endomysium antibodies will not be correctly diagnosed without small bowel biopsy.

Key Words

celiac disease IgA anti-endomysium antibodies IgA anti-gliadin antibodies small bowel biopsy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Holmes GKT, Prior P, Lane MR, Pope D, Allan RN: Malignancy in coeliac disease—effect of a gluten free diet. Gut 30:333–338, 1989Google Scholar
  2. 2.
    Valdimarsson T, Toss G, Ross I, Löfman O, Ström M: Bone mineral density in coeliac disease. Scand J Gastroenterol 29:457–461, 1994Google Scholar
  3. 3.
    Kilander AF, Dotevall G, Fällström SP, Gillberg RE, Nilsson LÅ, Tarkowski A: Evaluation of gliadin antibodies for detection of coeliac disease. Scand J Gastroenterol 18:377–383, 1983Google Scholar
  4. 4.
    Volta U, Lenzi M, Lazzari R, Cassani F, Collina A, Bianchi FB, Pisi E: Antibodies to gliadin detected by immunofluorescence and a micro-ELISA method: Markers of active childhood and adult coeliac disease. Gut 26:667–671, 1985Google Scholar
  5. 5.
    Friis SU, Gudmand-Højer E: Screening for coeliac disease in adults by simultaneous determination of IgA and IgG antibodies. Scand J Gastroenterol 21:1058–1062, 1986Google Scholar
  6. 6.
    Grodzinsky E, Hed J, Lieden G, Sjögren F, Ström M: Presence of IgA and IgG antigliadin antibodies in healthy adults as measured by micro-ELISA. Int Arch Allergy Appl Immunol 92:119–123, 1990Google Scholar
  7. 7.
    Bardella MT, Molteni N, Cesana B, Baldassarri AR, Bianchi PA: IgA antigliadin antibodies, cellbiose/mannitol sugar test, and carotenemia in the diagnosis of and screening for celiac disease. Am J Gastroenterol 86:309–311, 1991Google Scholar
  8. 8.
    Kelly CP, Feighery CF, Gallagher RB, Gibney MJ, Weir DG: Mucosal and systemic IgA anti-gliadin antibody in celiac disease. Contrasting patterns of response in serum, saliva and intestinal secretions. Dig Dis Sci 36:743–751, 1991Google Scholar
  9. 9.
    Mäki M, Holm K, Lipsanen V, Hällström O, Viander M, Collin P, Savilahti E, Koskimes S: Serological markers and HLA genes among healthy first-degree relatives of patients with coeliac disease. Lancet 338:1350–1353, 1991Google Scholar
  10. 10.
    Uibo O, Uibo R, Kleimola V, Jogi T, Mäki M: Serum IgA anti-gliadin antibodies in an adult population sample. High prevalence without celiac disease. Dig Dis Sci 38:2034–2037, 1993Google Scholar
  11. 11.
    Chorzelski TP, Sulej J, Tchorzewska H, Jablonska S, Beutner EH, Kumar V: IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann NY Acad Sci 420:325–334, 1983Google Scholar
  12. 12.
    Hällström O: Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis. Gut 30:1225–1232, 1989Google Scholar
  13. 13.
    Volta U, Molinaro N, Fusconi M, Cassani F, Bianchi FB: IgA antiendomysial antibody test. A step forward in celiac disease screening. Dig Dis Sci 36:752–756, 1991Google Scholar
  14. 14.
    McMillan SA, Haughton DJ, Biggart JD, Edgar JD, Porter KG, McNeill TA: Predictive value for coeliac disease of antibodies to gliadin, endomysium, and jejunum in patients attending for jejunal biopsy. BMJ 303:1163–1165, 1991Google Scholar
  15. 15.
    Ferreira M, Davies SL, Butler M, Scott D, Clark M, Kumar P: Endomysial antibody: Is it the best screening test for coeliac disease? Gut 33:1633–1637, 1992Google Scholar
  16. 16.
    Bürgin-Wolff, Gaze H, Hadziselimovic F, Huber H, Lentze MJ, Reymond-Berthet C: Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child 66:941–947, 1991Google Scholar
  17. 17.
    Alexander JOD: Dermatitis Herpetiformis.In Major Problems in Dermatology, Vol IV. A Rook (ed). London, WB Saunders, 1975, pp 236–280Google Scholar
  18. 18.
    Grodzinsky E, Franzen L, Hed J, Ström M: High prevalence of celiac disease in healthy adults revaled by antigliadin antibodies. Ann Allergy 69:66–70, 1992Google Scholar
  19. 19.
    Calabuig M, Torregosa R, Polo P, Tuset L, Tomás C, Alvarez V, Garsa-Vila A, Brines J, Vilar P, Farré C, Varea V: Serological markers and celiac disease: A new diagnostic approach? J Pediatr Gastroenterol Nutr 10:435–442, 1990Google Scholar
  20. 20.
    Garrote JA, Blanco A, Alonso M, Arranz E, Calvo C: Usefulness of antiendomysial antibodies as a serological marker in coeliac children. Pediatr Allergy Immunol 4:199–208, 1991Google Scholar
  21. 21.
    Cacciari E, Salardi S, Tiberi S, Volta U, Molinaro N, Bianchi FB, Bottazzo GF: Endomysial versus gliadin antibodies in diagnosis of coeliac disease in short children with no gastrointestinal symptoms. Lancet 338:521, 1991Google Scholar
  22. 22.
    Lindquist BL, Rogozinski T, Moi H, Danielssoon D, Olcén P: Endomysium and gliadin IgA antibodies in children with coeliac disease. Scand J Gastroenterol 29:452–456, 1994Google Scholar
  23. 23.
    Grodzinsky E, Hed J, Skogh T: IgA-anti-endomysium antibodies have a high positive predictive value for celiac disease in asymptomatic patients. Allergy 49:593–597, 1994Google Scholar
  24. 24.
    Peters MS, McEvoy MT: IgA anti-endomysial antibodies in dermatitis herpetiformis. J Am Acad Dermatol 21:1225–1231, 1989Google Scholar
  25. 25.
    Volta U, Molinaro N, de Franchis R, Forzenigo L, Landoni M, Frantangelo D, Bianchi FB: Correlation between IgA anti-endomysial antibodies and subtotal villous atrophy in dermatitis herpetiformis. J Clin Gastroenterol 14(4):298–301, 1992Google Scholar
  26. 26.
    Volta U, Bianchi FB: IgA antibodies to endomysium, gliadin and reticulin in silent coeliac disease. Lancet 339:242, 1992Google Scholar
  27. 27.
    Cooke WT, Holmes GKT: Clinical presentation.In Coeliac Disease. WT Cooke, GKT Holmes (eds). Edinburgh, Churchill-Livingstone, 1984, pp 251Google Scholar
  28. 28.
    Beutner EH, Kumar V, Chorzelski TP, Szaflarska-Czerwionka M: IgG endomysial antibodies in IgA deficient patient with coeliac disease. Lancet 1:1261–1262, 1989Google Scholar
  29. 29.
    Bayes T: An essay toward solving a problem in the doctrine of chance. Phil Trans R Soc 53:370–418, 1763Google Scholar
  30. 30.
    Corrao G, Corazza GR, Andreani ML, Torchio P, Valentini RA, Galatola G, Quaglino D, Gasbarrini G, di Orio F: Serological screening of coeliac disease: Choosing the optimal procedure according to various prevalence values. Gut 35:771–775, 1994Google Scholar

Copyright information

© Plenum Publishing Corporation 1996

Authors and Affiliations

  • Trausti Valdimarsson
    • 1
    • 2
    • 3
  • Lennart Franzen
    • 1
    • 2
    • 3
  • Ewa Grodzinsky
    • 1
    • 2
    • 3
  • Thomas Skogh
    • 1
    • 2
    • 3
  • Magnus Ström
    • 1
    • 2
    • 3
  1. 1.Department of Internal Medicine, Immunology & Infectious Diseases, Faculty of Health SciencesUniversity Hospital of LinköpingLinköpingSweden
  2. 2.Department of Pathology, Immunology & Infectious Diseases, Faculty of Health SciencesUniversity Hospital of LinköpingLinköpingSweden
  3. 3.Department of Microbiology, Immunology & Infectious Diseases, Faculty of Health SciencesUniversity Hospital of LinköpingLinköpingSweden

Personalised recommendations